The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Abstract
BACKGROUND Infectious complications and associated mortality are a major concern in acute pancreatitis. Enteral administration of probiotics could prevent infectious complications, but convincing evidence is scarce. Our aim was to assess the effects of probiotic prophylaxis in patients with predicted severe acute pancreatitis. METHODS In this multicentre randomised, double-blind, placebo-controlled trial, 298 patients with predicted severe acute pancreatitis (Acute Physiology and Chronic Health Evaluation [APACHE II] score > or =8, Imrie score > or =3, or C-reactive protein >150 mg/L) were randomly assigned within 72 h of onset of symptoms to receive a multispecies probiotic preparation (n=153) or placebo (n=145), administered enterally twice daily for 28 days. The primary endpoint was the composite of infectious complications--ie, infected pancreatic necrosis, bacteraemia, pneumonia, urosepsis, or infected ascites--during admission and 90-day follow-up. Analyses were by intention to treat. This study is registered, number ISRCTN38327949. FINDINGS One person in each group was excluded from analyses because of incorrect diagnoses of pancreatitis; thus, 152 individuals in the probiotics group and 144 in the placebo group were analysed. Groups were much the same at baseline in terms of patients' characteristics and disease severity. Infectious complications occurred in 46 (30%) patients in the probiotics group and 41 (28%) of those in the placebo group (relative risk 1.06, 95% CI 0.75-1.51). 24 (16%) patients in the probiotics group died, compared with nine (6%) in the placebo group (relative risk 2.53, 95% CI 1.22-5.25). Nine patients in the probiotics group developed bowel ischaemia (eight with fatal outcome), compared with none in the placebo group (p=0.004). INTERPRETATION In patients with predicted severe acute pancreatitis, probiotic prophylaxis with this combination of probiotic strains did not reduce the risk of infectious complications and was associated with an increased risk of mortality. Probiotic prophylaxis should therefore not be administered in this category of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the PROPATRIA trial in severe acute pancreatitis was stopped early because probiotics increased gut necrosis (9/152 vs. 0/144) and mortality (24/152 vs. 9/144) (Besselink et al., 2008).”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Besselink et al., 2008
In the citing paper
“live probiotics are contraindicated in septic shock, severe pancreatitis, and immunocompromised patients (PROPATRIA trial).”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Besselink et al., 2008
In the citing paper
“Nevertheless, multispecies probiotic formulations exacerbate intestinal damage, gut dysbiosis and bacterial translocation in AP patients experiencing organ failure (Besselink et al. 2008).”
From Odoribacter laneus protects intestinal barrier by bile acid-FXR axis in acute pancreatitis (2026) · cites this paper as Besselink et al. 2008
In the citing paper
“The most alarming report was published in 2008, showing increased mortality of severe acute pancreatitis following treatment with a multispecies probiotic preparation [22].”
From A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial (2010) · cites this paper as [22]
In the citing paper
“The patients who died had evidence of necrotizing jejunitis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [131]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
Bradley, E. L. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420170122019 · Cited by 2,756
Acute pancreatitis: value of CT in establishing prognosis.
Balthazar, E. J., Robinson, D. L., Megibow, A. J., & Ranson, J. H. (1990) · Radiology · doi:10.1148/radiology.174.2.2296641 · Cited by 1,696
UK guidelines for the management of acute pancreatitis
(2005) · Gut · doi:10.1136/gut.2004.057026 · Cited by 940
Heyland, D. K., Novak, F., Drover, J. W., Jain, M., Su, X., & Suchner, U. (2001) · JAMA · doi:10.1001/jama.286.8.944 · Cited by 907
Prognostic factors in acute pancreatitis.
Blamey, S. L., Imrie, C. W., O'Neill, J., Gilmour, W. H., & Carter, D. C. (1984) · Gut · doi:10.1136/gut.25.12.1340 · Cited by 727
Trends in the Epidemiology of the First Attack of Acute Pancreatitis: A Systematic Review
Yadav, D., & Lowenfels, A. B. (2006) · Pancreas · doi:10.1097/01.mpa.0000236733.31617.52 · Cited by 663
Isenmann, R., Rünzi, M., Kron, M., Kahl, S., Kraus, D., Jung, N., Maier, L., Malfertheiner, P., Goebell, H., & Beger, H. G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.050 · Cited by 511
Cited by
Banks, P. A., Bollen, T. L., Dervenis, C., Gooszen, H. G., Johnson, C. D., Sarr, M. G., Tsiotos, G. G., & Vege, S. S. (2013) · Gut · doi:10.1136/gutjnl-2012-302779 · Cited by 7,187
Self-citationMcClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
American College of Gastroenterology guideline: management of acute pancreatitis
Tenner, S., Baillie, J., DeWitt, J., & Vege, S. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.218 · Cited by 2,327
IAP/APA evidence-based guidelines for the management of acute pancreatitis
(2013) · Pancreatology · doi:10.1016/j.pan.2013.07.063 · Cited by 2,025
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Metadata
- Authors
- Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., Rosman, C., Ploeg, R. J., Brink, M. A., Schaapherder, A. F., Dejong, C. H., Wahab, P. J., van Laarhoven, C. J., van der Harst, E., van Eijck, C. H., Cuesta, M. A., Akkermans, L. M., & Gooszen, H. G.
- Affiliations
- University Medical Center Utrecht (NL)
- University Medical Center Groningen (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- St. Antonius Ziekenhuis (NL)
- Ziekenhuis Gelderse Vallei (NL)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Meander Medisch Centrum (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Rijnstate Hospital (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Gooszen, Hein G
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 371
- Issue
- 9613
- Pages
- 651-659
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2126413585
- Semantic Scholar
- 0c33c87f39f64a4e0c519a01dd62e3d8be441643
- Cited by
- 1,367
- References
- 43
- Citations by year
- 2026: 52 · 2025: 53 · 2024: 57 · 2023: 71 · 2022: 54 · 2021: 57 · 2020: 66 · 2019: 73 · 2018: 57 · 2017: 51 · 2016: 60 · 2015: 83 · 2014: 91 · 2013: 83 · 2012: 106
- FWCI
- 123.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- probiotics, acute pancreatitis, severe acute pancreatitis, infectious complications, probiotic prophylaxis, infected pancreatic necrosis, bacteremia, mortality, intestinal ischemia, enteral administration, APACHE II score, C-reactive protein
- MeSH terms
- Acute Disease, Adult, Aged, Aged, 80 and over, Double-Blind Method, Female, Humans, Male, Middle Aged, Netherlands, Pancreatitis, Placebos, Logistic Models, Treatment Outcome, Statistics, Nonparametric, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(08)60207-x
- The paper
- Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., Rosman, C., Ploeg, R. J., Brink, M. A., Schaapherder, A. F., Dejong, C. H., Wahab, P. J., van Laarhoven, C. J., van der Harst, E., van Eijck, C. H., . . . Gooszen, H. G. (2008). Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(08)60207-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.